In just eight weeks during the pandemic, women living with advanced cancer, ages 31 to 74, reported feeling more empowered, and less depressed, stressed, and anxious while using artificial intelligence to create personalized self-care plans infused with comedy and other relaxation techniques.
Continue readingIndustry News: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut microbiome could be an important factor in stroke risk and outcomes.
Continue readingIndustry News: Günenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis
The investigational medicine is being developed with the aim of providing patients suffering from pain associated with osteoarthritis with a well-tolerated, non-opioid therapy option that is intended to provide long-lasting pain relief and functional improvement of the affected joints.
Continue readingIndustry News: New Study Shows DCT Methods Helped Lung Cancer Trial Enrollment as COVID Surged
Remote and flexible trial approaches have been a hallmark of clinical trials during the pandemic and are widely believed to have been the primary factor in keeping trials open and operating. There is evidence showing that such measures as telehealth visits, off-site diagnostic/monitoring procedures and remote consenting were at least partially responsible for the ability of lung cancer trials to weather the storm.
Continue readingHelping People with Cancer Manage their Health: Home-based Clinical Trial
A collaborative virtual clinical trial will study the effectiveness of two digital therapeutics. Both digital therapeutics are anticipated to have an impact on mental and physical health when used adjunctively with multidisciplinary oncology care regimens.
Continue readingIndustry News: Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe Immunogenic
In adults who had previously received a full regimen of any of three COVID-19 vaccines granted Emergency Use Authorization or approved by the FDA, an additional booster dose of any of these vaccines was safe and prompted an immune response, according to preliminary clinical trial results reported in The New England Journal of Medicine.
Continue readingThe Trial Master File 10 Essentials for Success
A Trial Master File (TMF) is a collection of all essential trial documentation that enables effective monitoring, data integrity, and compliance throughout the lifecycle of a clinical trial. Learn about best practices and approaches for Trial Master File management.
Continue readingFDA Approves StrataGraft for the Treatment of Adults with Thermal Burns
The U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).
Continue readingLarge clinical trial to study repurposed drugs to treat COVID-19 symptoms
The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19.
Continue readingPositive Preclinical Data for SARS-CoV-2 Nose Spray Vaccine
Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 has significant advantages over injectables
Continue reading